The supplied material is an author-affiliation and contribution record rather than a research news article: it contains 131 institutional entries and describes how a large, international team coordinated the project, collected data, performed genome-wide association study (GWAS) and post-GWAS analyses, completed quality control, and wrote the manuscript. The contributors are affiliated with universities, hospitals, research institutes and companies across Europe, North America, Asia and Australia. The material does not include the study’s research question, results, publication date or conclusions.
Institutions and research networks
The affiliations include the Department of Complex Trait Genetics at Vrije Universiteit Amsterdam and Amsterdam Neuroscience in the Netherlands; the Centre for Precision Psychiatry at the University of Oslo and Oslo University Hospital; the University of Tokyo, RIKEN and Osaka University in Japan; and the University of Queensland and the University of Oxford.
Other participating institutions include the University of Copenhagen, Copenhagen University Hospital–Rigshospitalet, Karolinska Institutet, the University of Gothenburg, King’s College London, the University of Exeter, the University of Bergen, the Norwegian University of Science and Technology, and the University of Tartu.
The United States-based affiliations include Genentech, Regeneron Genetics Center, the Broad Institute of MIT and Harvard, Massachusetts General Hospital, Boston University, Harvard Medical School, the University of Pennsylvania, Geisinger Health System, Mayo Clinic, the University of Colorado Anschutz Medical Campus, the University of California, Los Angeles, Indiana University School of Medicine, and the Icahn School of Medicine at Mount Sinai.
Industry affiliations include Amgen deCODE genetics, Roche Pharma Research and Early Development, Janssen Research & Development, Eli Lilly and Company, Bayer AG and CHDI Management. The affiliations also include Strasbourg University Hospital in France, the Medical University of Vienna and Charité–Universitätsmedizin Berlin, as well as institutions in Denmark, Sweden, Iceland, Italy, Estonia, Czechia and Australia.
How the work was organized
The contribution statement says that project coordination was handled by researchers including A. Harder, A.I.C., A.M., A.M.H., A.Z., B.M.B., C.A.R., D. Rujescu, D.P., D.P.W., E.A.S., E.U., F.B., G. Selbæk, G.T., H.M.W., H.Z., I.K.K., I. Skoog, I.T.M., J.H., J.H.-L., J.M.G., J.M.S., J.Z., K.B., K.H., K.L., K.P., L.A., M.W.L., M. Waern, M. Ferreira, O.A.A., O.B., O.F., P.F.O., R. Hauger, R.Z., S.H., S. Kern, T.L., T.O., V.F., V.M. and Y.O.
Data collection involved contributors from the Alzheimer’s disease, aging, psychiatry, neurology, genetics and population-health groups listed in the source. The statement includes researchers such as A.A.S., A.-B.K., A.C., A.C.v.H., A.H.S., A.M., A.R., A.S., A.Z., A.d.B., B.A., B.C., B.-E.K., B.H., B.L., B.M.T., B.O.M., C.E., C.J., C. Mikkelsen, C. Ballard, D.A., D. Gudbjartsson, D.P.W., D.S., E.A., E. Sørensen, E. Stordal, F.H.D., F.J.W., G.B., G.B.W., G.J.B., G. Selbæk, G.T., G.W., H.B., H.E., H.H., H.U., H.Z., H. Seelaar, H. Stefansson, I.G., I.R., I. Saltvedt, I. Skoog, I.T.M., J.L., J. Snaedal, E.G.B.V., K.B., K.K., K.M., K.N., K.O., K.P., K.S., L.K.D., L. Pihlstrøm, L. Pålhaugen, M. Averina, M.G., M. Hulsman, M. Huisman, M.S.P., M.T., M.T.B., M.W.L., M. Waern, M. Wettergreen, M.Y., M. Franc, N.L. Pedersen, N.T., O.B.P., O.F., P.J.V., P. Svenningsson, Q.S.L., R.F.-S., R.S., S.B.S., S. Djurovic, S.J.v.d.L., S. Kern, S.R.O., S.T., S. Bahrami, S. Bergh, T.E., T.F., T.F.H., T.O., T. Truelsen, T.W., V.F., W.M.v.d.F. and Y.O.
Genomic analysis and quality control
The GWAS analysis was conducted by A.A.S., C.J., C. Benner, D.P.W., D.S., E.M., E.M.-G., E.U., G.T., J.Q.T., K.O., M.R.M., N.T., P.M.V., R.S., R.W., S.J.v.d.L., S. Bahrami, T.O. and Y.O.
Quality control was performed by A.A.S., A.M., A. Narita, A.Z., C. Benner, D.P.W., H.Z., I. Skoog, K.B., M. Waern, O.F., Q.S.L., S. Kern, S. Namba, T.K., T.O. and V.F.
Post-GWAS statistical analysis was carried out by A.L.v.S., A.M., C.J., C. Benner, D.P.W., D.S., E.U., J.B., K.O., M.S., N.Y.B., P.M.V., Q.S.L., R.S., S.J.v.d.L., T.N.P., T.O., X.W. and Y.O.
Biobank and consortium contributions
The source identifies several large-scale data collaborations. D.J.R., M.D.R., J.W., N.N., G. Sirugo, A. Poindexter, Y.-A.K., K.P.N., J. Dever, A. Harvey, S.L., M. Livingstone, F.V., S. DerOhannessian, T. Tran, J. Stephanowski, S.S., N.H., J. Dunn, A.V., C.M.K., M.R., R.J., C.W., S.S.V., S. Damrauer, Y. Bradford, S. Dudek and T.D. are listed as part of the Penn Medicine Biobank.
A. Buchanan, D.J.C., C.L.M., M.N.M., K.R. and D. Rolston are listed as members of the GHS–RGC DiscovEHR collaboration. Researchers from Mayo Clinic are identified as part of the Mayo Clinic–RGC Project Generation, while contributors from the University of Colorado are identified as part of the Colorado Center for Personalized Medicine–RGC Collaboration.
Additional participating groups include the UCLA–RGC ATLAS collaboration, INDIANA-CHALASANI and the Mount Sinai Million Health Discoveries Program. The statement also names the Alzheimer’s Disease Working Group of the Psychiatric Genomics Consortium (PGC-ALZ), led by O.A.A. and D.P., with E.U. and D.P.W. as lead analysts.
Manuscript preparation
The manuscript was written by A.A.S., A.Z., D.P., D.P.W., E.A.S., E.M., E.U., G. Selbæk, H.Z., I. Skoog, J.B., K.B., M.S., M. Waern, O.A.A., R.W., S. Djurovic, S. Kern, S. Bahrami, T.O. and V.F. The supplied record does not provide the manuscript’s title, findings, publication date or details of the underlying analyses beyond these contribution descriptions.
Source: www.nature.com


